The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
So the Al goes on about the market for ava6000 but do his figures even take into account the increase of market due to the numbers of cancer suffers where Dox is contraindicated due heart toxicity? Given the avg age of cancer sufferers- I would imagine that would expand the market significantly? Just wondering if that was clarified or whether Al’s comments that they were conservative estimates of market and he had not factored that in.
Thread is showing ‘-1 replies’ … the derampers couldn’t be more negative ;-)
OR.....
No one is selling so they keep having to rise the SP to try to close....
Who knows, but it is a nice change.
The AIM Index is not controlled by H&L. The AIM Risers is different will be probably generated by today's data for SP movement... H&L are notoriously bad with being up to date data wise particularly in the morning. It helps if you signed in as well as they delay prices for people not signed in. Their watchlists that you can save were reformatted about 6 months ago and they only just managed to stop the boxes from resizing during price changes...it was nauseating.
Looks like he has been over to Germany for a while… came back with an extra ‘n’
Ophidian - I have always been fascinated by the science. I don’t think you have to be a scientist to know that they MUST have means of measuring/estimating activation or even non activation as potentially this could express itself in some kind of potentially unexpected and unwelcome way. I will do some more research when able.
I welcome this kind of discussion to the board … what I would discourage is the deramping and in equal measures ramping. If we could just stick to the science it would be a more pleasant place.
Jesus quer got a wedgy or something? I’m saying I don’t think dose escalation CONFIRMS activation but DO think ethics come into play at SOME POINT. If you have run clinical trials and have some insight then I’d be glad to hear it or discuss what data they might be collecting to ascertain activation. That would at LEAST be interesting- rather than all the tripe ramping and deramping here.
Well - I am not trying to imply there must be hope because of my questions. I am wondering what can be inferred and genuinely interested in what could be measured. If they are receiving data that indicates that activation is not taking place then I do wonder when ethical considerations would be taken. I have seen threads that posturing that one person may have potentially died of unrelated causes (not unlikely given covid) and we have moved to dose escalation. There are many things that could be inferred from that but I completely agree a negative outcome is still possible. I just disagree that there won’t be data that indicates activation… and if there was data that suggestion activation was unlikely then ethics would most certainly come into play…. But at one point I don’t know
Just me thinking out loud but IF there were no signs of it activating would it not be unethical to move to dose escalation? The information we have is that there is consistent data. I suspect the data they were mostly referring to is mostly about heart toxicity and side effects. What else can be measured at this stage? Tumour scans ? What else could blood work show in terms of activation? Genuine question…
That is great news - it is nice to hear people’s good news … so much bad around at the moment that I think we need some perspective.
Mapp - lol PL. aim is a game… and the rest of the poems
Clearly some deleted … what have I missed ? Nothing interesting I presume.
Bish back but truant has had its bot posts removed...
Would it be not that the other aspect of the dose escalation is that there should be some evidence of therapeutic efficacy- otherwise it would be unethical to continue no? In other words is the risk that it is doing nothing at all reduced ?
Yes - I agree that they will probably just laugh - or it won’t make it past the comms team and just filed in the round filing cabinet. I do think that shorting ‘can’ negatively impact the progress of a companies efforts but then I guess if that was a concern to BODthe company shouldn’t be public. I think this will just have to run its course and I’m sure there will be a period before June where they close before they get their potential kicking. As LTH we can hope that timeline is wrong and they leave it too long. As for TW - he is just a complete low life. It is one thing to short a share quietly but the kind of ring he runs is more in the grey area of what is legal. Grey being - can anyone prove he is doing it?
The interesting aspect of this tactic is that if the major institutional shorts can be influenced the TW BS shorts will burn (and all the ‘PI’ shorter wannabes) so credit where credit due, chaps and chap-esses
Bump - let the ‘feasters’ fester on their own.
Right now it is a battle of shorters and LTH. Shorters will want LTH to sell and I’m sure some with think I could make some money back by selling and buying back lower. The question is how low will it go. Doing that there are risks… as soon as a Jupiter and Bronte close out the price will shoot up. PI Shorts will get squeezed. TW’s cropped up but reward is limited now, so sooner or later these bottom feeders will get bored and cut their risk and PI shorters will get lose. As someone said - the market works against PIs both ways.
It is a gamble to short - and you better be sat there all trading day. You don’t know when the shorts will close or when an RNS will drop. There will not be a fundraise for at least the next 6 months and there will be expectations of news (potentially excellent news) by summer. This means that the price will rise and the shorts will close. As a LTH I will just wait for that. No news on AVA6000 until then is very good news. GL genuine holders.
Indeed - look at bit coin shorters who are leveraged … wiped out by whales all the time.
So the FUD spammers wouldn’t be able to converse on most of your post as they probably don’t understand AVA6K nor have they read an Avacta RNS. They resort to posting repetitious threads with low SPs titles like they are trying to bait who exactly? If I wasn’t prepared to sell at £1 am I really gonna sell at 60p? Those that we’re likely to sell have sold already and this blatant attempt to attract more sellers and put off buyers is obvious to all LTH. It will get harder and harder for these attempts to be fruitful so I imagine this is just the beginning of the offensive posting.
I would agree with the sentiment about ignoring, but the problem is that you can’t ignore the obvious downtrend in the SP - you do have to be realistic otherwise it just appears as a ramp. I personally think that it is better to do what you have done here, counter all the FUD but let’s have a different thread title such as ‘Avacta investors discussion’. If LTH are committed to only posting on threads with titles that are neutral and also commit to filtering / not responding to the trolls then we might get some decent discussions. Hard to organise on an anonymous board. Also happy to move discussions with elsewhere with some better moderation. Easier said than done.